Background/Aim-Nitric oxide (NO) may be involved in non-adrenergic noncholinergic (NANC) inhibitory innnervation of the sphincter of Oddi (SO). The effects of topical application of glyceryl trinitrate (GTN), a NO donor, upon SO motility were examined. Methods-Nineteen patients undergoing routine SO manometry for investigation of abdominal pain were studied. After routine recording of SO motility, they were randomised into three groups to receive 10 ml of normal saline, 5 mg GTN (0.5 mg/ml) or 10 mg (1 mg/ml) GTN. 
Delivery ofbile into duodenum is controlled by hepatic bile secretion, gall bladder contraction and the sphincter of Oddi (SO). The hormone cholecystokinin (CCK) is believed to be responsible for postprandial gall bladder contraction and SO relaxation. Recent studies have shown that the effect of CCK upon the SO is mediated through stimulation of the nonadrenergic non-cholinergic (NANC) nerves' and nitric oxide (NO) is an important element of this pathway. 2" There have been few studies on the effect of NO on the function of the SO. Slivka et al localised the presence of NO synthase (NOS) in nerve fibres and bundles of human SO and demonstrated that topical application of S-nitroso-N-acetylcysteine (SNAC), an NO donor, inhibits SO motility.5 However, SNAC needs to be freshly prepared, is not stable over a prolonged period of time, and is not widely available. The aim of the present study was to examine the effect of glyceryl trinitrate (GTN; Nitrocine, Schwarz Pharma, UK), a form of NO donor that is commercially available, on SO motility.
Methods

PATIENTS
Patients undergoing routine SO manometry for investigation of upper abdominal pain were examined. The majority of patients underwent manometry for investigation of postcholecystectomy pain with a median duration of 2 1 (SD 1-5) years after surgery. Only two patients still had gall bladder in situ. None of the patients was on regular medication with nitrates or calcium channel blockers. All of the patients had been investigated with normal abdominal ultrasound scans and endoscopic retrograde cholangiopancreatography (ERCP) before manometry. normal saline to 0 5 mg/ml; GTN 5). The proximal channel was disconnected from the perfusion system and the drug solutions were then infused into the channel over 1 minute. Hg accompanied by tachyoddia (frequency of 12 contraction per second); she was randomised to saline. The second patient who was randomised to 10 mg GTN also had tachyoddia although tonic SO pressure was normal.
There was a non-significant increase in basal SO tonic pressure, amplitude and frequency of phasic activity after injection of 10 ml normal saline (Fig 1) . In contrast, mean tonic SO basal pressure and all the variables of phasic SO activity significantly diminished after injection with 5 mg and 10 mg GTN; specifically, phasic contractions became significantly less frequent, were shorter in duration, and had decreased amplitude. Consequently, the motility indices fell from 312 (35) mm Hg min to 40 (19) mm Hg min in the group who received GTN 5 mg and from 462 (125) to 57 (27) mm Hg min in the higher dose GTN group (Fig 2) . These effects were seen both in patients who had normal SO function and in those who had abnormal SO motility. In the human gastrointestinal tract, non- which is an inhibitor of smooth muscle contraction." Identification of NOS in a subpopulation of myenteric nerves supports the physiological role of NO in the regulation of intestinal motility. Complex neurogenic and hormonal mechanisms are involved in the control of SO muscle tone and motility. Ingestion of a meal'2 and injection of CCK'3 produce a decrease in SO basal pressure and amplitude and reduce the frequency of phasic contractions, thereby facilitating bile flow into the duodenum. 
